Ibex Wealth Advisors purchased a new position in shares of The Allstate Co. (NYSE:ALL - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 2,951 shares of the insurance provider's stock, valued at approximately $569,000.
A number of other hedge funds have also recently added to or reduced their stakes in the stock. FSA Wealth Management LLC acquired a new stake in shares of Allstate during the 3rd quarter worth $26,000. Northwest Investment Counselors LLC acquired a new stake in Allstate during the third quarter worth about $28,000. Catalyst Capital Advisors LLC bought a new position in Allstate in the 3rd quarter valued at about $29,000. Peoples Bank KS acquired a new position in shares of Allstate in the 4th quarter valued at approximately $49,000. Finally, Transamerica Financial Advisors Inc. acquired a new stake in shares of Allstate during the 3rd quarter worth approximately $58,000. Institutional investors own 76.47% of the company's stock.
Allstate Trading Down 0.6 %
NYSE:ALL traded down $1.23 on Friday, reaching $192.60. 1,619,418 shares of the stock traded hands, compared to its average volume of 1,687,967. The firm has a market capitalization of $51.00 billion, a price-to-earnings ratio of 12.47, a price-to-earnings-growth ratio of 1.45 and a beta of 0.52. The Allstate Co. has a 1-year low of $153.42 and a 1-year high of $209.88. The company has a current ratio of 0.40, a quick ratio of 0.40 and a debt-to-equity ratio of 0.43. The company's 50 day moving average is $193.92 and its 200-day moving average is $188.46.
Allstate (NYSE:ALL - Get Free Report) last released its earnings results on Wednesday, October 30th. The insurance provider reported $3.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.20 by $1.71. Allstate had a net margin of 6.77% and a return on equity of 26.67%. The business had revenue of $16.63 billion for the quarter, compared to analyst estimates of $14.57 billion. During the same quarter in the previous year, the business earned $0.81 earnings per share. Allstate's revenue for the quarter was up 14.7% on a year-over-year basis. Equities research analysts anticipate that The Allstate Co. will post 16.96 EPS for the current fiscal year.
Allstate Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Thursday, January 2nd. Investors of record on Friday, November 29th were given a dividend of $0.92 per share. The ex-dividend date was Friday, November 29th. This represents a $3.68 annualized dividend and a dividend yield of 1.91%. Allstate's payout ratio is 23.83%.
Analysts Set New Price Targets
Several research analysts have commented on the stock. Morgan Stanley boosted their price objective on shares of Allstate from $220.00 to $228.00 and gave the company an "overweight" rating in a research report on Thursday, November 7th. Wells Fargo & Company lifted their target price on Allstate from $186.00 to $187.00 and gave the company an "equal weight" rating in a research report on Tuesday, January 14th. BMO Capital Markets increased their target price on shares of Allstate from $205.00 to $214.00 and gave the stock an "outperform" rating in a report on Friday, October 18th. Barclays decreased their price target on shares of Allstate from $187.00 to $183.00 and set an "underweight" rating on the stock in a report on Monday, January 6th. Finally, Evercore ISI raised shares of Allstate from an "in-line" rating to an "outperform" rating in a research note on Wednesday, January 8th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating, fourteen have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $218.13.
Read Our Latest Report on Allstate
Allstate Company Profile
(
Free Report)
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Featured Articles

Before you consider Allstate, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Allstate wasn't on the list.
While Allstate currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.